جست‌وجوی استاد و پژوهشگر

Claire Russellمشاهده پروفایل

دانشیار

• Developmental Neurobiology
• Translational Neurobiology
• Zebrafish Models
• +۶ مورد دیگر

Claire Russell serves as Associate Professor in Developmental and Translational Neurobiology within the Department of Comparative Biomedical Sciences at the Royal Veterinary College (RVC). Her research leverages zebrafish ( Danio rerio ) models to investigate neurodegenerative mechanisms in Neuronal Ceroid Lipofuscinoses (NCLs/Batten disease), epilepsy, and ataxia, with emphasis on microglial function, autophagy, and mitochondrial dysfunction. She earned her BSc from Imperial College London (1991) and DPhil from the University of Sussex (1995), conducting postdoctoral work at Imperial College, King's College London, and University College London. Her lab operates under core values of Equity, Respect, Commitment, Curiosity, and Integrity, fostering an inclusive research environment through structured recruitment and daily practices. Russell's research program exploits zebrafish advantages—rapid development, optical transparency, and genetic tractability—for high-throughput drug discovery and mechanistic studies. Recent publications reveal strong trends in mitochondrial pathology (ATPase inhibitory factor 1 dysfunction), autophagy defects in NCLs, and cross-species modeling of lysosomal storage disorders. Her group develops zebrafish models for CLN2/CLN3 diseases and collaborates on drug repurposing studies targeting seizure reduction and neuroprotection. Fellow of the Higher Education Academy Associate of the Royal College of Science She has mentored over 50 PhD/Master's students and secured major funding including MRC (£1m for CLN3 personalized medicine), EU H2020 BATCure (€6m), and Batten Disease Family Association grants. Current projects focus on lysosomal storage disorder mechanisms, blood-brain barrier therapeutics, and microglia-neuron interactions. Russell leads the Brain Health and Behaviour research group, teaches developmental biology courses, coordinates placement years, and conducts extensive school outreach including CRB-checked classroom visits and work experience programs.

Liran Einavمشاهده پروفایل

استاد

• Industrial Organization
• Health Economics
• Insurance Markets
• +۴ مورد دیگر

Liran Einav is a Professor in the Department of Economics at Stanford University, where he serves as Research Associate Director of the Industrial Organization Program. His work spans multiple NBER programs including Industrial Organization, Economics of Aging, and Economics of Health. Einav's research focuses on industrial organization, health economics, and insurance markets. His work examines healthcare spending patterns, market design in insurance markets, nursing home quality, racial disparities in healthcare, and the economic implications of medical technologies. He frequently collaborates with Amy Finkelstein and other leading economists in the field. His recent publications analyze racial differences in nursing home quality, clinician behavior in response to skin-tone affecting medical tests, the economic impact of having a child with Down syndrome, and market design considerations in regulated health insurance markets. His work often leverages large administrative datasets and natural experiments to draw causal inferences about economic behavior in healthcare markets. Einav has made significant contributions to understanding selection and moral hazard in insurance markets, building on the empirical framework he developed with Finkelstein and Cullen (2010). His work has implications for health insurance design, Medicare policy, and understanding healthcare spending patterns in the United States. He maintains active research collaborations across economics and health policy, with recent work examining telemedicine adoption, emergency department utilization, and end-of-life healthcare spending. His research combines theoretical insights with rigorous empirical analysis to address pressing questions in health economics and industrial organization.

Ivy K. Hoمشاهده پروفایل

دانشیار

• Health Psychology
• Women's Health
• Asian American Studies
• +۴ مورد دیگر

Ivy K. Ho is an Associate Professor of Psychology in the College of Fine Arts, Humanities and Social Sciences at the University of Massachusetts Lowell, specializing in Clinical Health Psychology. Her work focuses on health disparities among women with multiple marginalized identities using intersectional and social ecological frameworks. Her academic credentials include: Ph.D. in Health Psychology from the University of Louisville (2004) M.A. in Clinical Psychology from the University of Colorado at Colorado Springs (1999) B.A. in Psychology from the University of Kentucky (1996) Postdoctoral Fellowship in Pediatric Pain Psychology at Cincinnati Children's Hospital Medical Center (2004-2006) Dr. Ho's research investigates how interpersonal stress (traumatic and non-traumatic) impacts health outcomes, with emphasis on cultural competence in healthcare delivery for Asian American and Southeast Asian American women. Her work bridges health psychology, psychophysiology, and victimization studies to address systemic barriers in medical settings. Analysis of her 15 most recent publications (2018-2008) reveals consistent focus on trauma, sexual harassment, and health disparities among Asian American women. Key trends include cultural adaptation mechanisms, microaggressions in healthcare, and physiological correlates of stress, often through collaborative projects addressing Southeast Asian American health equity. Her scientific recognition includes: Division on Women Award (2011) from the Asian American Psychological Association Young Investigator's Travel Award (2004) from the American Pain Society Teaching Award from UMass Lowell's Department of Psychology Graduate Fellowship Award from the University of Louisville (1999) Psi Chi International Honors Society membership (1994) Dr. Ho has secured significant research funding including an NSF grant for the INCLUDE-Women project examining micro-inequities, multiple UMass Lowell seed grants on Southeast Asian American health, and community-focused initiatives like the Southeast Asian Digital Archive. Her mentoring efforts target underrepresented students through programs such as Recruitment and Retention of Cambodian Americans Majoring in Psychology.

Gerardo Turcattiمشاهده پروفایل

استاد مدعو

• Drug Screening
• Chemical Biology
• Bio-analytical Chemistry
• +۵ مورد دیگر

Gerardo Turcatti is an Adjunct Professor at the School of Life Sciences (EPFL), leading the Biomolecular Screening Facility (BSF) and the Biomolecular Screening Core Facility. He holds roles in SSV-Teaching and directs the ACCESS program under the NCCR-Chemical Biology initiative. With a Master's in Chemical Engineering (University of Geneva) and a PhD in Chemistry and Biochemistry (EPFL, where he won the best doctoral thesis award), his expertise spans multidisciplinary R&D in drug screening, chemical biology, and bio-analytical chemistry. His research focuses on high-throughput screening technologies, including holographic imaging for cardiomyocyte dynamics and red blood cell storage studies. He has pioneered platforms for malaria drug discovery and cancer therapeutics, leveraging 3D tumoroid models and combinatorial chemistry. His work extends to antiviral research, including SARS-CoV-2 inhibitors and canine distemper virus studies, and includes innovations in nucleic acid sequencing technologies through his former role as CTO of Manteia S.A. Key Projects: ACCESS platform, BSF facility, Next-Gen sequencing tech development Teaching: Leads the 'Methods: from disease models to therapy' course, integrating hands-on platform rotations in life sciences Labs/Teams: Directs EPFL's Biomolecular Screening Facility and collaborates with industry and academic partners Publications emphasize translational applications, including drug repurposing, cardiovascular toxicity screening, and red blood cell storage optimization. His contributions bridge academic research and industrial innovation, with over 100 peer-reviewed articles and patents in chemical biology and drug discovery.

Ryan Woodsمشاهده پروفایل

استادیار

• Epidemiology
• Biostatistics
• Disease Surveillance
• +۵ مورد دیگر

Ryan Woods is an Assistant Professor in the University of British Columbia's Faculty of Health Sciences and an Executive Director, Data and Analytics at BC Cancer. He holds a Scientist position in the Department of Cancer Control Research at BC Cancer Research Institute. His academic journey includes a PhD in Population and Public Health from UBC, an MSc in Statistics, and a BSc in Mathematics from the University of Guelph. Dr. Woods' research focuses on leveraging administrative and registry data to address cancer control challenges, particularly in oncology outcomes, cancer screening equity, and health system performance. His work emphasizes international benchmarking, equity gaps in service utilization, and data-driven health policy. Key areas include evaluating disparities in breast cancer screening participation among immigrant populations, analyzing pandemic impacts on cancer diagnosis timing, and optimizing team-based cancer care models. His publications span over two decades, with recent emphasis on pandemic-related healthcare disruptions, multimorbidity trends, and global cancer survival disparities. He has contributed to CONCORD-3 and ICBP initiatives analyzing international cancer outcomes. Dr. Woods also leads BC Cancer's data strategy, integrating biostatistics and epidemiology to advance population health surveillance. His expertise bridges clinical and population-level research, with a focus on translating data insights into actionable strategies for improving cancer care equity and system efficiency. Current projects include spatial access analysis for lung screening programs and modeling pandemic-driven health burden shifts.

• Health Economics
• Health Technology Assessment
• Child and Caregiver Health
• +۵ مورد دیگر

Dr. Sheena Arora is a Senior Research Fellow at the University of Technology Sydney's Centre for Health Economics Research and Evaluation (CHERE). Her work focuses on health economics, particularly in child and caregiver health, health technology assessment, and economic evaluations of psychosocial interventions. She holds academic affiliations with the Faculty of Health and has contributed to studies on incontinence management, opioid prescribing patterns, and newborn screening programs. Her research employs advanced methodologies like discrete choice experiments and cost-effectiveness analysis. Education: BSc in Nutrition and Economics (UNSW Australia, 2001-2004) Master of Public Health (University of Sydney, 2008-2009) Research Interests: Economic evaluation of pharmaceuticals and medical devices Nurse-led interventions for childhood cancer survivors Cost-benefit analysis of screening programs Discrete choice experiments to quantify informal care Grants & Projects: Lead investigator on newborn screening genomics (NHMRC Ideas Grant) Economic evaluation of IMBED incontinence intervention NSW Drug & Alcohol Consultation Liaison Service evaluation Her work bridges clinical practice and policy, with over 30 peer-reviewed publications and active engagement in national health technology assessment processes through the PBAC and MSAC.

Merran Findlayمشاهده پروفایل

پژوهشگر ارشد

• Nutrition and Dietetics
• Clinical Nutrition
• Nutritional Science
• +۳ مورد دیگر

Dr. Merran Findlay is a Senior Research Fellow at UNSW Sydney and Clinical Associate Professor at The University of Sydney, specializing in cancer nutrition for over 25 years. She serves as Board Director for the Clinical Oncology Society of Australia and Australia and New Zealand Head and Neck Cancer Society. Her work bridges clinical practice with implementation science in nutrition assessment, malnutrition management, and value-based healthcare. Senior Research Fellow – Living Better With and After Cancer, Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group Clinical Appointments: Royal Prince Alfred Hospital, Chris O’Brien Lifehouse Leadership Roles: Co-founder of Implementation Science networks at UNSW and The University of Sydney Her research focuses on nutrition interventions in head and neck cancer, sarcopenia assessment, and evidence-based guideline implementation. She explores how nutritional status affects clinical outcomes, treatment complications, and healthcare costs through international multicenter studies and digital health innovations. Current research trends show strong emphasis on head and neck cancer nutrition , sarcopenia biomarkers , and implementation science for guideline adoption. Her work spans nutrition assessment , enteral nutrition , and health services research , with recent articles addressing AI integration in quality indicators and sarcopenia severity quantification. Dr. Findlay leads implementation programs like the Sydney Health Partners Implementation Science Program and conducts extensive audits including INFORM (International Nutrition Audit in Foregut Tumors). Her collaborative efforts involve developing CT-based sarcopenia metrics and optimizing nutrition counseling frequency during cancer treatment.

• Public Health
• Epidemiology
• Bone Health
• +۳ مورد دیگر

Siri Forsmo is the Dean of the Faculty of Medicine and Health Sciences at Norwegian University of Science and Technology (NTNU), a position she has held since March 2021. Prior to this, she served as Head of the Department of Community Medicine and Nursing (2017–2021) and Head of the Department of Community Medicine (2013–2017). She holds a Professorship in Community Medicine. She earned her Cand. med. (1985) from the University of Trondheim, a Master of Public Health (1990) from the University of Tromsø, and a Dr.med. (1997) from NTNU. Her research focuses on screening consequences, osteoporosis and fractures, public health, cancer diseases, and epidemiological methods. She has contributed to studies on the effects of screening programs, bone health outcomes in populations, and the intersection of chronic diseases with bone health. Her work emphasizes epidemiological and qualitative approaches to understand health disparities and improve public health strategies. Key areas of research include: Screening program ethics and psychosocial impacts (e.g., mammography false positives) Osteoporosis epidemiology and fracture risk factors Health inequalities and mortality patterns post-fracture Longitudinal studies on chronic disease management (HUNT and NOREPOS cohorts) Her articles explore topics like genetic variants influencing bone health, urban-rural health disparities, and drug utilization patterns for osteoporosis. She has also written opinion pieces on healthcare policies, such as the role of pharmacies in health services. Professional contributions include leadership in academic medicine, mentorship in community health research, and collaboration with national health initiatives. She has advised on public health strategies and remains active in clinical practice with a background in gynecology and general medicine.

• Colorectal Cancer (CRC)
• Tumor Metabolism
• Cancer Drug Resistance
• +۳ مورد دیگر

Elisabeth Letellier is an Assistant Professor at the University of Luxembourg's Faculty of Science, Technology and Medicine (FSTM), leading the Molecular Disease Mechanisms group within the Department of Life Sciences and Medicine. Her research focuses on dissecting molecular mechanisms underlying colorectal cancer (CRC) progression, drug resistance, and tumor microenvironment interactions. She collaborates with institutions like the Integrated BioBank of Luxembourg (IBBL) and Laboratoire National de la Santé (LNS) to develop patient-derived 3D tumor models and in vivo systems for translational research. With over 40 publications (H-index 27, 3196 citations) and securing €9M in competitive grants since 2013, her work also includes contributions to three patents, two as primary author. Research interests include metabolic reprogramming in tumor cells, microbiome-driven cancer progression, and stromal cell interactions. She teaches molecular medicine in the Master in Molecular and Computational Biomedicine program, emphasizing protein structure and biochemistry practical training. Her team's achievements include collecting over 180 high-quality CRC patient samples and advancing drug repurposing strategies targeting KRAS/BRAF mutations. Current projects explore formate-driven metastasis mechanisms, ketogenic diet effects, and gut microbiome modulation in cancer therapy.

Bilal Javedمشاهده پروفایل

استادیار

• Industrial Biotechnology
• Nanotechnology
• Drug Delivery Systems
• +۴ مورد دیگر

Dr. Bilal Javed is an Assistant Lecturer (equivalent to Assistant Professor) in Biochemistry at the School of Food Science and Environmental Health, Technological University Dublin. His research focuses on nanotechnology applications in biomedicine, food safety, and sustainable agriculture. He leads a multidisciplinary group developing biomimetic drug-delivery systems, 3D cell culture platforms, and advanced biosensors for pathogen detection. Education: PhD in Biological Sciences, PMAS Arid Agriculture University & University of Pennsylvania (2020) Marie Skłodowska-Curie Postdoctoral Fellowship, TU Dublin (2021-2024) Postgraduate Certificate in University Learning and Teaching, TU Dublin (2023) MSc Pharmaceutical Quality Assurance and Regulation (ongoing) Research Interests: Dr. Javed's work spans nanotechnology, drug delivery, biosensing, and environmental health. His group synthesizes supramolecular assemblies for targeted cancer therapy, develops nanomaterial-based rapid diagnostic tools for food contaminants, and explores sustainable agricultural applications of nanomaterials. Research aligns with UN Sustainable Development Goals in health and environmental protection. Research Trends: Recent publications demonstrate strong focus on nanomaterial applications in oncology (glioblastoma, breast cancer), lateral flow assays for mycotoxin detection, nanoparticle synthesis optimization, and plant pathology interventions. Multidisciplinary approaches combine biochemistry, materials science, and digital technologies. Awards and Honors: Top 2% most cited young scientist globally (Stanford/Elsevier 2022) Marie Skłodowska-Curie Postdoctoral Fellowship (€250,000) International Research Support Initiative Program fellowship ($15,000) SATLE Funding for AI in biomanufacturing (€5,000) Grants and Supervision: Secured multiple PhD scholarships including ARISE (€134,000 x3) and Government of Ireland awards. Supervises projects on marine biotoxin detection, brain cancer nanotherapies, and mycotoxin biosensors. Manages Nano Lab Research Centre safety protocols and serves as year tutor for Pharmaceutical Healthcare programs. Labs and Teams: Leads multidisciplinary research group at TU Dublin's Nano Lab Research Centre. Active in COST Actions: Net4Brain, EURESTOP, ENOTTA, and PlasTHER. Collaborates internationally with researchers from USA, Pakistan, and EU institutions.

• Behavioral Science
• Implementation Science
• Public Health
• +۴ مورد دیگر

Jamie Marie Faro is an Assistant Professor at UMass Chan Medical School in the Population and Quantitative Health Sciences department under the T.H. Chan School of Medicine . She is also affiliated with the Morningside Graduate School of Biomedical Sciences in both Masters in Clinical Investigation and Population Health Sciences departments. Education: BS - Exercise Science, Lasell University MS - Exercise Science, George Washington University PhD - Exercise & Health Sciences, University of Massachusetts Boston Dr. Faro specializes in behavioral and implementation science with focus areas in physical activity, diet, smoking cessation and mHealth approaches . Her work emphasizes cancer survivorship, cardiovascular risk reduction and digital health interventions for at-risk populations. Her recent research trends show extensive work in 2024-2025 with publications spanning mHealth for cancer survivors , electronic referrals , digital divide risk scores , smoking cessation technologies , and implementation science methodologies . Key journals include JMIR Cancer , BMC Public Health , and JAMA Network Open . Scientific Awards Institute for Implementation Science Scholars (IS-2) 2021-2023 Dr. Faro has received significant grants including: NHLBI K01 (2022-2026) for ActivityChoice program, NCI T32 fellowship (past), and NIA 1R01AG076757 (2022-2026) as Co-Investigator. She also served as Pilot PI for NCATS 5UL1TR001453 (2023) related to survivorship care coordination. As co-chair of the Massachusetts Comprehensive Cancer Coalition Survivorship Health Equity Task Committee , she collaborates with the UMass Cancer Center and teaches implementation science courses. Her work integrates electronic health records , community partnerships and patient decision aids to improve health outcomes.

Sebastian Amigorenaمشاهده پروفایل

پژوهشگر

• Immunology
• Cell Biology
• Antigen Presentation
• +۶ مورد دیگر

Sebastian Amigorena is a CNRS Research Director and Research Team Leader at Institut Curie, Paris , heading the Immune Responses and Cancer team (Unit: Immunity and Cancer, U932). His career spans fundamental immunology, cell biology, and translational cancer research. PhD in Paris (1990) Postdoctoral fellowship at Yale University Founded INSERM AVENIR group (1995) Research Focus : Interdisciplinary work at immunology-cell biology interfaces, pioneering antigen presentation and cross-presentation mechanisms in dendritic cells, T cell exhaustion dynamics, and transposable elements' role in anti-tumor immunity. His team uses cutting-edge approaches like RNAseq, ChIP-Seq, intravital microscopy, and mouse models. Publication Trends : Recent work emphasizes transposable elements, tumor immunity, and epigenetic regulation of T cell memory and exhaustion. Earlier studies established foundational knowledge in IgG receptor functions and dendritic cell phagocytosis. Scientific Recognition : 2025: Franco-Brazilian chair for CellAction's cell therapy platform 2021: Two RHU program awards for innovative cancer research Collaborations & Grants : Key partnerships with Mnemo Therapeutics (75M€ spin-off funding), CellAction platform, and CNRS. His team includes permanent researchers, engineers, and PhD student Darawan Tabtim-on . Laboratory : Investigates dendritic cell membrane transport, chromatin organization in T cell differentiation, and transposable elements' impact on tumor immunity. Technologies span proteogenomics, single-cell RNA-seq, and in vivo CRISPR screens.

Helen Colhounمشاهده پروفایل

استاد

• Diabetes
• Medical Informatics
• Epidemiology
• +۵ مورد دیگر

Helen Colhoun is a Professor at the University of Edinburgh , holding the AXA Research Fund Chair in Medical Informatics and Life Course Epidemiology . She leads the Diabetes Medical Informatics and Epidemiology group within the Institute of Genetics and Cancer , with additional affiliations to the Usher Institute and BHF Centre for Cardiovascular Science . Her work bridges genomics , epidemiology , and machine learning to advance diabetes research. Research Interests : Diabetes complications (cardiovascular, renal, retinopathy) Integration of e-health records (EHR) and omics data Development of prediction models for clinical and self-management Design of clinical trials for diabetes therapies Collaborations on hypoglycaemia studies and pharmacoepidemiology Notable Projects : Scottish Diabetes Research Network (SDRN) initiatives SDRNT1BIO bioresource for type 1 diabetes Hypo-RESOLVE consortium for hypoglycaemia research REACT-SCOT for pandemic-era diabetes-COVID-19 analysis Scientific Awards : AXA Research Fund Chair in Medical Informatics Students & Collaborations : PhD students: Amara Nwagbata , Xuan Zhou Collaborators in Medical Research Council Human Genetics Unit , Centre for Population Health Sciences , and European institutions

Tim Aitmanمشاهده پروفایل

استاد

• Genetics
• Genomics
• Epigenetics
• +۵ مورد دیگر

Professor Tim Aitman serves as Chair of Molecular Pathology and Genetics and Director of the Centre for Genomic and Experimental Medicine within the University of Edinburgh’s Institute of Genetics and Cancer, holding an Honorary Consultant Physician position with NHS Lothian. He leads the Scottish Genomes Partnership and founded the One Health Genomics Edinburgh network with over 600 researchers. His affiliations extend to the CRUK Edinburgh Centre and BioCaptiva, a spinout company developing cell-free DNA capture technology. His research integrates classical genetics with cutting-edge genomic technologies to investigate rare and common human disorders. Key focus areas include: Genetic basis of insulin resistance syndromes and autoimmune diseases like systemic lupus Next-generation sequencing for rare disease diagnosis (familial hypercholesterolemia, Ehlers-Danlos, nephrotic syndrome) Liquid biopsy development for cancer stratification using cell-free DNA analysis Evolutionary genomics through rat genome sequencing projects His work has pioneered methods for identifying complex trait genes and demonstrated copy number variation’s role in immune diseases. Professor Aitman’s publication portfolio shows strong emphasis on translational genomics, with recent articles focusing on liquid biopsy applications in prostate cancer radiotherapy, acute aortic syndromes, and oropharyngeal cancer. His research consistently bridges basic genomic discovery with clinical implementation, particularly in cancer diagnostics and rare disease genomics. His scientific recognition includes: Fellowship in the Royal Colleges of Physicians of London and Edinburgh Fellowship in the Academy of Medical Sciences Senior Fellowship at the PHG Foundation Specialist Adviser for the House of Lords Science and Technology Committee As principal investigator, he has secured over £30 million in research funding from major bodies including MRC, ERC, CRUK, and AstraZeneca. His leadership extends to the BioCaptiva spinout (£3M+ investment) and the University of Edinburgh’s COVID-19 testing program (TestEd). Current projects focus on cell-free DNA biomarkers for radiotherapy adaptation and acute disease monitoring. He directs the Centre for Genomic and Experimental Medicine at Edinburgh’s Western General Hospital campus, fostering collaborations across the Institute of Genetics and Cancer. His One Health Genomics network integrates veterinary and human genomic research, while partnerships with CRUK Edinburgh Centre and NHS Lothian drive clinical translation of genomic technologies.

• Mycotoxin Research
• Fungal Secondary Metabolites
• Plant-Fungal Interactions
• +۹ مورد دیگر

Gerhard Adam is an Associate Professor at the Institute of Microbial Genetics, Department of Biotechnology and Food Sciences, University of Natural Resources and Life Sciences, Vienna (BOKU). His research focuses on mycotoxin metabolism, plant-fungal interactions, and microbial genetics, with a strong emphasis on Fusarium species and their impact on food safety. He leads and participates in numerous national and international research projects, including those funded by the Austrian Science Fund (FWF), EU, and industry partners. His academic work centers on understanding the molecular mechanisms of mycotoxin production, detoxification, and resistance, particularly in cereals. Key areas include the role of UDP-glucosyltransferases in deoxynivalenol (DON) resistance, the formation of masked mycotoxins, and the metabolic fate of toxins in plants and animals. He has made significant contributions to the development of biological assays and genetic tools for studying Fusarium virulence and plant resistance. The recent publications highlight a consistent focus on metabolomics, enzyme characterization, and the biochemical transformation of mycotoxins. Trends show increasing use of stable isotope-assisted techniques, LC-HRMS, and functional genomics to dissect detoxification pathways. Research spans from fundamental fungal biochemistry to applied food safety solutions, including bioremediation strategies using bacterial lactonases and engineering plant resistance. Selected Scientific Contributions: Project leadership in FWF-funded SFB F37-Fusarium program (2009–2019) Development of yeast bioassays for Fusarium mycotoxins Characterization of UDP-glucosyltransferases involved in DON detoxification Discovery of novel Fusarium metabolites (e.g., gramiketides) Investigation of fumonisin self-resistance mechanisms in fungi Adam actively supervises research theses and collaborates widely within BOKU and international consortia such as FFoQSI and the World Mycotoxin Forum. He regularly presents at major scientific conferences and contributes to public science communication through media and outreach reports. Laboratories and Research Teams: Institute of Microbial Genetics, BOKU Tulln Collaborative work with Institute of Bioanalytics and Agro-Metabolomics FFoQSI – Competence Centre for Food and Biotechnology International Fusarium research network